Rituxan lupus is becoming an option for the treatment of the disease for several reasons. One of the reasons is that increased or abnormal B-cell activity is a factor in lupus and other autoimmune diseases and can be treated with drugs such as rituxan. Indeed, rituxan has the ability to decrease the number of B defective B cells attacked by lupus related symptoms.
The rituxan mode of action against B cells includes attacking the B cells that are still in transition phase, or in an adolescent phase. These cells are unable to participate in the immune system response to intruders thus the attack by the drug. Doctors have noticed that patients who took rituxan improved and had more healthy B cells.
Meanwhile, these patients have few mature cells thus their immune system is unable to mount a responsive attack against bacteria and viruses. It thus becomes important to monitor this group of patients closely for risks of infections.
On the…





